{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:44:16Z","timestamp":1778697856471,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T00:00:00Z","timestamp":1118620800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1590\/s1807-59322005000300005","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T10:50:10Z","timestamp":1136890210000},"page":"207-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["EFFECT OF ANTIRETROVIRAL DRUGS ON MATERNAL CD4 LYMPHOCYTE COUNTS, HIV-1 RNA LEVELS, AND ANTHROPOMETRIC PARAMETERS OF THEIR NEONATES"],"prefix":"10.1016","volume":"60","author":[{"given":"Patr\u00edcia","family":"El Beitune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcyone Artioli","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Maria","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto A.","family":"Figueir\u00f3-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Abduch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1590\/S1807-59322005000300005_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1590\/S0041-87812004000100005","article-title":"HIV-1: maternal prognosis","volume":"59","author":"El Beitune","year":"2004","journal-title":"Rev Hosp Cl\u00edn Fac Med S Paulo"},{"issue":"2","key":"10.1590\/S1807-59322005000300005_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1590\/S1413-86702004000200004","article-title":"Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children","volume":"8","author":"El Beitune","year":"2004","journal-title":"Braz J Infect Dis"},{"issue":"RR-18","key":"10.1590\/S1807-59322005000300005_bib4","first-page":"1","article-title":"Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR"},{"key":"10.1590\/S1807-59322005000300005_bib5","author":"Perinatal HIV Guidelines Working Group Members"},{"issue":"1","key":"10.1590\/S1807-59322005000300005_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.32.5.793","article-title":"Intrauterine growth as estimated from live-born birth-weight data at 24 to 42 weeks gestation","volume":"32","author":"Lubchenco","year":"1963","journal-title":"Pediatrics"},{"issue":"13","key":"10.1590\/S1807-59322005000300005_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1590\/S1807-59322005000300005_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/sti.79.6.448","article-title":"A pilot study to evaluate the safety and feasibility of the administration of AZT\/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil","volume":"79","author":"Lambert","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"6","key":"10.1590\/S1807-59322005000300005_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1471-0528.2004.00147.x","article-title":"Perinatal HIV-1 transmission among low income women participants in the HIV\/AIDS Control Program in Southern Brazil: a cohort study","volume":"111","author":"Kreitchmann","year":"2004","journal-title":"BJOG"},{"issue":"4","key":"10.1590\/S1807-59322005000300005_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1590\/S1413-86702002000400003","article-title":"Predictors of undetectable plasma viral load in HIV-positive adults receiving antiretroviral therapy in Southern Brazil","volume":"6","author":"Silveira","year":"2002","journal-title":"Braz J Infect Dis"},{"key":"10.1590\/S1807-59322005000300005_bib11","author":"Perinatal HIV Guidelines Working Group Members"},{"issue":"3","key":"10.1590\/S1807-59322005000300005_bib12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S0004-282X2004000400011","article-title":"Anthropometric cranial measures of normal newborn","volume":"62","author":"Mota","year":"2004","journal-title":"Arq Neuro-Psiquiatr"},{"issue":"2","key":"10.1590\/S1807-59322005000300005_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":"Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219\/076 Teams","volume":"281","author":"Culnane","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1590\/S1807-59322005000300005_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.282.6.527-a","article-title":"Infant growth after in utero exposure to zidovudine","volume":"282","author":"Zuccotti","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1590\/S1807-59322005000300005_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ajcn\/74.6.814","article-title":"Determinants of low birth weight among HIV-infected pregnant women in Tanzania","volume":"74","author":"Dreyfuss","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1590\/S1807-59322005000300005_bib16","first-page":"173","article-title":"Maternal HIV infection and the anthropometric characteristics of children at birth in Burkina Faso","volume":"9","author":"Sombie","year":"1999","journal-title":"Sante"},{"issue":"10","key":"10.1590\/S1807-59322005000300005_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004310050941","article-title":"Anthropometric indicators of human immunodeficiency virus infection in infants with early and late symptoms in the first months of life","volume":"157","author":"Agostoni","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"24","key":"10.1590\/S1807-59322005000300005_bib18","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of adverse outcome","volume":"346","author":"Tuomala","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1590\/S1807-59322005000300005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003510","article-title":"Antiretroviral for reducing the risk of mother-to-child transmission of HIV infection","author":"Brocklehurst","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1590\/S1807-59322005000300005_bib20","unstructured":"Duarte G, Quintana SM, Mussi-Pinhata MM. Impact of maternal HIV-infection on obstetrical and early neonatal outcome: a nine-year experience (abstract). XI International Conference on AIDS, Vancouver, British Columbia, Canada, June, 1996: Tu. C. 2572."},{"issue":"6","key":"10.1590\/S1807-59322005000300005_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-3476(97)70032-5","article-title":"Incidence of premature birth and neonatal respiratory disease in infants of HIV positive mothers","volume":"131","author":"Martin","year":"1997","journal-title":"J Pediatr"},{"issue":"6","key":"10.1590\/S1807-59322005000300005_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00002030-199806000-00014","article-title":"Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group","volume":"12","author":"Leroy","year":"1998","journal-title":"AIDS"},{"issue":"8","key":"10.1590\/S1807-59322005000300005_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1590\/S1807-59322005000300005_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1067\/mob.2002.123407","article-title":"Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome","volume":"186","author":"Ellis","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1590\/S1807-59322005000300005_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/314637","article-title":"Efficacy of zidovudine and hyperimmune human immunodeficiency virus immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group Protocol 185","volume":"179","author":"Stiehm","year":"1999","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1590\/S1807-59322005000300005_bib26","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1097\/00002030-200012220-00013","article-title":"Combination antiretroviral therapy and duration of pregnancy","volume":"14","author":"The European Collaborative Study and The Swiss Mother and Child HIV Cohort Study","year":"2000","journal-title":"AIDS"},{"issue":"16","key":"10.1590\/S1807-59322005000300005_bib27","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1590\/S1807-59322005000300005_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00126334-200304010-00006","article-title":"Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women","volume":"32","author":"European Collaborative Study","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1590\/S1807-59322005000300005_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission","volume":"29","author":"Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"suppl","key":"10.1590\/S1807-59322005000300005_bib30","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/plac.2001.0670","article-title":"Vertical HIV-1 transmission: prophylaxis and paediatric follow-up","volume":"22","author":"Carneiro","year":"2001","journal-title":"Placenta"},{"issue":"4","key":"10.1590\/S1807-59322005000300005_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2337\/diacare.28.4.856","article-title":"Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant","volume":"28","author":"El Beitune","year":"2005","journal-title":"Diabetes Care"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222031817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222031817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/pdf\/clin\/v60n3\/24457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:19:40Z","timestamp":1761722380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222031817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1807593222031817"],"URL":"https:\/\/doi.org\/10.1590\/s1807-59322005000300005","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EFFECT OF ANTIRETROVIRAL DRUGS ON MATERNAL CD4 LYMPHOCYTE COUNTS, HIV-1 RNA LEVELS, AND ANTHROPOMETRIC PARAMETERS OF THEIR NEONATES","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1590\/S1807-59322005000300005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}